Evidence map›Paper›PMID 41658987›Full record

ReviewFrontiers in bioengineering and biotechnology2026

Bridging biology and technology: the rise of 3D bioprinting advancements in infection research.

Sajad Mohammadi, Wendy W J Unger, Aldo Ferrari, Caterina Sanchini, Giancarlo Ruocco, Salvatore D'Alessandro

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sajad MohammadiLaboratory of Pediatrics, Department of Pediatrics, Sophia Children's Hospital, Erasmus University Medical Center (Erasmus MC), Rotterdam, Netherlands.
Wendy W J UngerLaboratory of Pediatrics, Department of Pediatrics, Sophia Children's Hospital, Erasmus University Medical Center (Erasmus MC), Rotterdam, Netherlands.
Aldo FerrariHylomorph AG, Technopark, Zurich, Switzerland.
Caterina SanchiniCenter for Life Nano - & Neuro -Science - CLN2S, Italian Institute of Technology (IIT), Rome, Italy.
Giancarlo RuoccoCenter for Life Nano - & Neuro -Science - CLN2S, Italian Institute of Technology (IIT), Rome, Italy.
Salvatore D'AlessandroCenter for Life Nano - & Neuro -Science - CLN2S, Italian Institute of Technology (IIT), Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of infectious diseases and rapid pathogens' evolution have highlighted the urgency for developing new therapeutics to protect public health and the economy from massive loss. Drug discovery for infectious diseases involves a multi-stage and multi-disciplinary pipeline, often leading to increased risk and mortality due to the prolonged course. However, advancements in technology have been reshaping the field by offering alternative

Indexed as

3D bioprintingbiomaterialsdisease modelingdrug discoveryin vitromulticellular systems

Identifiers

PMID41658987
PMCPMC12876209

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.